Abstract: As our understanding of biological pathways and the genes that regulate these pathways increases, consideration of these biological pathways has become an increasingly important part of genetic and molecular epidemiology. Pathway-based genetic association studies often involve genotyping of variants in genes acting in certain biological pathways. Such pathway-based genetic association studies can potentially capture the highly heterogeneous nature of many complex traits, with multiple causative loci and multiple alleles at some of the causative loci. In this paper, we develop two nonparametric test statistics that consider simultaneously the effects of multiple markers. Our approach, which is based on data-adaptive U-statistics, can handle both qualitative data such as casecontrol data and quantitative continuous phenotype data. Simulations demonstrate that our proposed methods are more powerful than standard methods, especially when there are multiple risk loci each with small genetic effects. When the number of disease-predisposing genes is small, the data-adaptive weighting of the Ustatistics over all the markers produces similar power to commonly used single marker tests. We further illustrate the potential merits of our proposed tests in the analysis of a data set from a pathway-based candidate gene association study of breast cancer and hormone metabolism pathways. Finally, potential applications of the proposed tests to genome-wide association studies are also discussed. 
pathway activity levels determine the phenotype of interest, it is expected that different mutations in different genes within this pathway can lead to similar phenotypes. Instead of evaluating single candidate genes, pathway-based genetic association studies consider entire pathways comparing a dozen or more genes or multiple pathways that link up or compete in complex genetic networks.
However, such genetic heterogeneity can lead to loss of power to detect genetic associations (Slager et al., 2000; Schaid et al., 2005) when single marker-based analysis is used due to weak marginal effect and the issues of adjusting for multiple testing. An alternative approach is based on haplotype association tests; however, since genes within a given pathway are often from different chromosomes, haplotype analysis of functional variants does not make biological sense.
In addition, tests based on haplotypes often have large degrees of freedom, resulting in loss of power. As an alternative to haplotype analysis, new multilocus association tests have also been developed for tagSNPs within a region of interest (Kwee et al., 2008) .
Genetic heterogeneity among genes within pathways suggests that one may want to develop tests for joint testing between multiple genes or SNPs with complex phenotypes and to draw an overall conclusion as to whether the set of SNPs is related to the disease risk. One can use linear/logistic regression to simultaneously test the main effects (and possibly interactions) of multiple SNPs. Although this approach can be more powerful than testing each marker separately (Longmate, 2001) , it still suffers from weak power because of the large number of degrees of freedom. Schaid et al. (2005) proposed a nonparametric test of association of multiple SNPs and disease status using U-statistics (Hoeffding, 1948) and presented several interesting choices of kernel functions. Their approach first measures a score over all markers for pairs of subjects and then compares the averages of these scores between cases and controls. The power of the proposed tests depends on the choice of the kernel used in the U-statistics. When there are both protective and disease-predisposing genes in the gene set, use of the wrong kernel can result in a loss in power, especially for the allele-match kernel. This is due to the fact that comparing average similarities between cases and controls is influenced by how much the allele frequencies depart from equality within a group and thereby potentially eliminating a signal when summing these allele-match kernels across markers (Schaid et al., 2005) . The linear dosage kernel, which is defined as the sum of the number of the minor allele for a pair of genotypes, suffers the same potential loss of power when the minor alleles across multiple markers are both protective and disease predisposing, as indicated by their simulations (Schaid et al., 2005) .
In this paper, we propose an alternative U-statistics-based nonparametric test of the association between multiple SNPs and qualitative traits using data-adaptive U-statistics. Following Sen (2006) , we consider defining our test statistics based on both the within-group and betweengroup U-statistics, instead of simply considering the contrast between case and control genotype U-statistics scores. Also different from Schaid et al. (2005) , our proposed test can be applied to qualitative traits of more than two categories and is more robust in power to misspecification of the genetic models. We also propose a nonparametric test of association between multiple SNPs and quantitative traits by extending the idea of Wei and Johnson (1985) . We propose to weight the U-statistics across different markers using the negative of the logarithm of the single marker p-values, which makes the final test statistics data-adaptive. Such weighting increases the test power, especially when there are only one or two disease-associated markers in the marker set.
Both tests are based on U-statistics that do not require a particular parametric model of dependence imposed on the SNPs or model to relate the genotypes to the phenotypes and therefore are robust to misspecfication of the underlying genetic models.
The rest of the paper is organized as follows: in the Statistical Methods section, we describe the U-statistics-based tests for both qualitative and quantitative traits. To illustrate the properties of our methods, we perform simulations. We also apply our methods to a study of candidate genes for breast cancer risk and age of onset of breast cancer, to illustrate their utility and interpretation. Finally, we give a brief discussion of the methods.
U-statistics-based test of association for qualitative traits
We first introduce notation. Suppose that we have K SNPs from genes in a given pathway or from genes with similar molecular functions, each with two alleles 0 and 1, where without loss of generality, we assume that allele 1 is the minor allele. At each SNP, there are three genotypes, coded as G = {00, 10, 11}. We consider a qualitative trait, taking C different possible categorical values. For example, for case-control studies, there are two trait groups with C = 2. Let n c be the number of individuals in the cth phenotype group. Let X ci = (X ci1 , · · · , X ciK ) be the observation vector over the K SNPs for the ith individual in the cth group, for i = 1, · · · , n c , where X cik is the genotype of the ith individual in the cth group at the kth SNP that takes one of the three possible genotype values in G. The probability law of X ci is denoted by π c = {π c (g) :
where π c (g) is the probability of observing genotype g in phenotype group c. We are interested in testing the null hypothesis of homogeneity of the π c , c = 1, 2, · · · , C.
Since the space of the alternative hypotheses is very large, the standard multi-way contingency table analysis to test for global association suffers loss of power. Instead, following Sen (2006), we consider defining a test statistic based on the U-statistics (Hoeffding, 1948) . We first define a symmetric kernel between a pair (i, j) of observations X i = {X i1 , · · · , X iK } and
where w k is a SNP-specific weight. This kernel function can be regarded as a weighted Hamming distance between individuals i and j over the K SNPs. Note that the definition of this kernel does not depend on particular specifications of the high-or low-risk alleles. The weight can be defined based on prior knowledge of the importance of the K SNPs. Alternatively, we can take a data-adaptive weight as w k = − log(P k ) where P k is the p-value based on a univariate test for the kth SNP. Using this weight, the SNPs with smaller p-values are given larger weights.
Instead of simply considering the difference of the kernel (1) between cases and controls as in Schaid et al. (2005) , we propose to derive a test statistic following Sen (2006) by considering both the within-group and the between-group U-statistics. Specifically, for phenotype group c, we define the within-group U-statistic as
where n ckg is the number of individuals in the cth group for which at the kth SNP the observed genotype label is g. Note that if the within-group genotypes are all the same, then U cc = 0.
Similarly, for phenotype group c and c , we define the between-group U-statistic as
From this equation, we note that a larger difference in genotype distribution between the cth and the c th group corresponds to a larger value of U cc .
Let n = n 1 + n 2 + · · · + n C be the total number of individuals across all the C phenotype groups and let U 0 be the pooled group U-statistic corresponding to the same kernel φ, which can be written as
which can then be decomposed into within-group component W and between-group component B, where U cc and U cc are defined as in equations (2) and (3). Under the null hypothesis, B has zero expectations and it is positive under the alternative. We define the following statistic for testing the association between K genotypes and a discrete phenotype,
which is the ratio of the between-group contribution versus the within-group contribution to the pooled U-statistic. For data-adaptive weights w k = − log(P k ), which depends on the data, the and obtain the permutation-based
Nonparametric tests for quantitative traits
In this section, we consider constructing a test for testing the association between a group of SNPs and a quantitative trait phenotype Y based on the U-statistics. Let Y i be the observed trait value for the ith individual for i = 1, · · · , n. Let X i = (X i1 , · · · , X iK ) be the observation genotype vector over the K SNPs for the ith individual for i = 1, · · · , n, where X ik is the genotype of the ith individual at the kth SNP that takes one of the three possible genotype values G = {00, 10, 11}, where we assume that allele 1 is the minor allele. The hypothesis that we wish to test is To define the U-statistics, for marker k, we define the set S gk = {i : X ik = g, i = 1, · · · , n} the individuals with genotype g at the kth marker for g ∈ G and k = 1, · · · , K and let m gk = |S gk | be the number of such individuals. Consider a kernel function between two trait values Y i and
We define the following U -statistics for SNP k,
which compare the quantitative trait values between every two genotype groups at the SNP k,
and θ k1 and θ k2 are similarly defined. Under the null hypothesis, θ kj = 0 for j = 0, 1, 2 and let U kj = U kj0 , j = 1, 2, 3. In order to combine these three U-statistics, we assume that the quantitative trait value is a monotone function of the number of the minor allele at the trait-associated SNPs and further define
To define a statistic over K SNPs, we consider the multivariate U-statistic (U 1 , · · · , U K ) , which has limiting normal distribution with zero mean, and limiting covariance matrix Σ = ((σ kl )). It is easy to show that Σ can be consistently estimated byΣ (see Appendix). In order to draw an overall conclusion on association between the K SNPs and the quantitative trait, we consider a linear combination of the statistics U k0 defined as the test statistic
where w k is a data-adaptive weight. We consider the data-adaptive weight
where P k is the p-value based on a univariate test for the kth SNP, and r k = corr(Y, g k ) is the correlation between the observed trait values Y = {Y 1 , · · · , Y n } and the genotypes g k at the kth SNP coded by counting the numbers of minor alleles. The rationale of using the sign of the correlation in the weight is to account for the fact that the minor alleles across all of the K SNPs can either increase or decrease the trait phenotype. We then define a statistic for testing the association between K genotype and a continuous trait as
Using the data-adaptive weight vector, the asymptotic distribution of the test statistic T c is no longer the standard normal distribution. Its significance level is again estimated using permutations by randomly permuting the continuous trait values across all the individuals.
Finally, if we can make an assumption on the mode of inheritance as dominant or recessive, we can similarly define a U-statistics-based test statistic based on comparing two genotype groups, {00} vs. {10,11} for the dominant model or {00, 10} vs. {11} for the recessive model.
Simulation Studies
We performed simulations to evaluate the power of the proposed U-statistics-based tests and to compare with some of the standard methods. Since significance levels of the proposed test statistics are determined by permutations of the phenotypes, the type 1 errors of these tests are automatically controlled and we therefore did not report the results of the type 1 error evaluations.
Simulation studies for qualitative traits
For the first simulation study, we generated the data set as described in Schaid et al. (2005) .
In this simulation, the genotypes for 10 independent markers were simulated. Of these 10, the number of markers associated with disease ranged from 1 to 10. The frequency of each high-risk allele, for all markers, was set to 0.15. Hardy-Weinberg proportions were used to generate the genotypes for the controls, and the genotypes for cases were generated by assuming that the high-risk allele had a multiplicative effect on the odds ratio. The effect per allele was set at an odds ratio of 1.5. The total sample size was set to 500 individuals, of which half were cases and half were controls. All simulations were based on 500 replicates. For each replicate, 50,000
permutations were used to estimate the p-values.
The top panel of Figure 1 shows the power of the four different tests, including the unweighted For the second simulation study, we fixed the disease prevalence at 5%. Briefly, we generated genotypes for 10 independent markers, with the number of markers associated with the disease loci ranging from 1 to 10. All markers had minor allele frequency 0.3 and the genotypes were generated following Hardy-Weinberg proportions in the general population. The minor alleles were designated as the high-risk alleles. We assigned penetrance as P r
, where g i ∈ {0, 1, 2} is the number of risk alleles at disease locus i and D ∈ {1, . . . , 10} is the number of disease loci. This is equivalent to assuming multiplicative effects across disease loci on the odds scale. The parameters β i were chosen so that the locusspecific sibling recurrence risk ratio λ s = 1.02, corresponding to genotype relative risks of 1.34 and 1.79 for having one and two copies of the risk alleles, respectively. The intercept β 0 was chosen so that the population disease prevalence was 5%. The second panel of Figure 1 shows the power of the three different tests for three different α-levels and a different number of disease genes ranging from 1 to 10. Similar patterns were observed as in previous simulations.
For the last set of simulations, we considered the model where the minor alleles correspond to both disease-predisposing and protective loci among the SNPs considered. The simulation set-up was the same as the second simulation study except that for markers 2, 4, 6, 8 and 10, the corresponding βs were negative so that the minor alleles were protective. Similar patterns were observed as in previous simulations for the proposed U-statistics-based tests. However, the bottom panel of Figure 1 shows that Schaid's test using a "linear-dosage" kernel can have very low power under these conditions when there are both disease-predisposing and protective minor alleles. This is expected, since in Schaid's U-statitics, the scores derived from both diseasepredisposing and protective minor alleles can potentially cancel each other out and hence can eliminate any potential signal for the association.
Simulation studies for quantitative traits
To evaluate the performance of the proposed U-statistics-based test for quantitative traits, we simulated the trait values based on the following model,
where X k = 0, 1, 2 for the three genotypes at the kth disease gene, and is error term following N (0, 1). We considered the scenarios when there are 1-10 disease genes. For each disease gene, we chose the minor allele frequency and the regression coefficient to explain 1% of the total trait variance when considered individually. Specifically, for minor allele frequencies of 0.1, 0.3 and 0.5, the corresponding βs are 0.24, 0.16 and 0.14, respectively. For each model, 500 individuals were simulated for each replicate and a total of 500 replicates were performed. For each simulation, 50,000 permutations were used to estimate the p-values. In addition, we observed a very small loss of power when there were only one or two disease markers. We also observed that when the minor allele frequency is 0.1, the number of individuals in the 11 genotype group is small and the resulting U-statistic test based on three genotype groups is not as powerful as the test based on two genotype groups by assuming dominant models (results not shown). However, when the minor allele frequency is not too small, the U-statistics tests using three genotype groups can lead to a gain in power (see the fourth row of Figure 2 ).
Simulation based on LD
We also evaluated whether the proposed tests can gain power in the analysis of SNP data that are in LD with the disease variants. To simulate such data, we used the algorithm of Durrant et al.
(2004). We downloaded the phased genotype data for 60 CEU (CEPH samples with ancestry from northern and western Europe) founder subjects from HapMap release #21 (www.hapmap.org).
As the reference data, we picked the haplotypes of 11 SNPs on chromosome 6, SNP 6 (MAF = 0.25) was assigned as the disease locus, and the minor allele was designated as the risk allele with locus-specific sibling recurrence risk ratio λ s = 1.02 and 1.05. The disease locus displayed moderate to strong LD with the other SNPs in the CEU samples, with r 2 values ranging from 0.47 to 0.83. We simulated m cases and m controls (m = 500, 1000). For each individual, we first generated genotypes at the pre-determined disease locus and assigned one allele to each of Instead, the 120 CEU founder haplotypes are used to generate plausible haplotypes that may be representative of a wider population. The disease locus genotypes were removed prior to data analysis. For each simulation, 50,000 permutations were used to estimate the p-values. 
Application to Real Data Sets
In this section, we present applications of the proposed methods for analysis of an association between the genes in the hormone metabolism pathway and the risk of breast cancer and breast cancer age of diagnosis.
Application to breast cancer case-control data set
It has long been recognized that female hormones, whether endogenous or exogenous, can be risk factors for female cancers (Davis and Sieber, 1997). In order to explore the cause of susceptibility to these hormone-associated cancers, we undertook a population-based association study of genetic variants in candidate steroid hormone metabolism genes and cancer risk. The Women's Insights and Shared Experiences (WISE) study used incident breast cancer cases and frequencymatched controls selected from the community using random digit dialing (RDD). Additional details of our study design can be found in Strom et al. Table 1 presents the p-value for each SNP based on the univariate logistic regression, indicating that the two polymorphisms in CYP1B1, the SNP in CYP3A4 and one polymorphism in SULT1A1 are associated with the risk of breast cancer. After Bonferroni correction for multiple testing, CYP3A4 A729G and SULT1A1 A667G remain significant at the 0.01 level. Both of these associations are biologically plausible: these genotypes are associated with altered estrogen and catecholestrogen metabolism, and would be predicted to alter breast cancer risk (Raftogianis et al., 1999; Amirimani et al., 2003) .
In order to demonstrate our proposed tests, we applied various statistical methods for testing the overall association between the 11 variants in the metabolism pathway and breast cancer risk. 
Application to breast cancer age of diagnosis data set
We next examined whether the genetic variants in hormone metabolism pathway are associated with age of breast cancer diagnosis among the cases in the WISE data set. The last column of Table 1 shows the p-value from simple linear regression analysis for each SNP, indicating that CYP1A2 is associated with early onset among the breast cancer patients (p=0.018). However, the result is not statistically significant after the Bonferroni adjustment for multiple testing. 
Discussion
Since many complex phenotypes are expected to be controlled by many genes each with small effects, single-marker tests of association can suffer a great loss of power due to genetic heterogeneity and multiple testing. A large body of biological knowledge suggests that genes often work as networks of pathways instead of acting alone to affect phenotype and disease risk. Since these pathways often have complex interactions and feedback loops, it would not be surprising to find that multiple genes within a biological pathway are associated with these complex phenotypes. This makes pathway-based genetic association analysis an attractive approach for identifying genes related to complex phenotypes. In this paper, we have proposed data-adaptive U-statistics-based tests for testing the association between multiple markers in a pathway and a phenotype. Our approach is quite general and does not require any parametric assumptions on the trait values or genetic models. This approach is particularly useful for pathway-based candidate gene association studies, where SNPs in a candidate gene can be tested simultaneously for association with the phenotype using knowledge of biological functions. Our simulation results demonstrate that our approach performs similarly to the U-statistic test defined by Schaid et al., (2005) and can be more powerful than standard single-marker-based methods under some conditions. However, our test statistic has better power than Schaid's test when there are both high-risk and protective minor alleles of the SNPs among the SNP set. Application to the WISE breast cancer data sets illustrates the potential merits of our statistics over the standard single-SNP analysis.
In this paper, we studied only the kernel function φ(., .) defined using the Hamming distance (see equation (1)) for the qualitative phenotype, and the kernel defined by trait value difference for the quantitative phenotype. These kernels are chosen without making strong assumptions on genetic models and trait distribution and tend to be more robust in power as compared to for example the linear kernel used by Schaid et al. (2005) . However, other kernel functions can be considered in the definition of the U-statistics. For example, for the quantitative phenotype, rank-based kernel defined by φ(x, y) = 1 if y > x and 0 otherwise, can be used. For the qualitative phenotype, Schaid et al. (2005) presented several interesting kernels that can be applied in combination with our definitions of the U-statistics. However, some of these kernels are sensitive to model assumption, which can lead to lower power if the assumption is not met.
The proposed methods also have potential applications in genome-wide association studies (GWAS). GWAS often involve genotyping of hundreds of thousands of SNPs. For example, the Illumina 550K array can be used to type approximately 550,000 SNP markers on each individual.
To account for allelic heterogeneity, one may want to perform joint tests of all the SNPs in both intragenic and regulatory regions of a given gene using the proposed test statistics. This genebased association analysis makes more biological sense since genes, not the SNPs, are the true functional unit of biology (Neale and Sham, 2003) . Additionally, one can also consider using pathway databases to perform pathway-based analysis for GWAS. An interesting direction for future research is to develop methods for analysis of data from GWAS, where the SNP data have natural hierarchical structures, i.e., genes belong to pathways, and SNPs belong to genes. When there are many pathways under consideration, our proposed tests can be applied to each of the pathways and the false discovery rate (Benjamini and Hochberg, 1995; Efron, 2004) procedure can be used for correcting for multiple pathways. Alternatively, a recently developed non-parametric pathway-based regression (Wei and Li, 2006) can be used for selecting the relevant pathways.
Detailed comparisons of these different approaches deserve further investigation.
In summary, we have proposed two U-statistics-based tests that provide a simultaneous test of association of multiple genetic markers with complex phenotypes. The tests can be applied to pathway-based association analysis and have potential applications in gene-based genetic association analysis in genome-wide genetic association studies. 
Appendix
We provide some details on estimating the covariance matrix under the null hypothesis that the markers are not associated with the phenotype for the proposed test statistic T c defined in equation (6). For SNP k and l, we have
We provide some details on estimating E(U k1 U l1 ). Other terms can be estimated similarly. When p = 1, q = 1, we have
For the quadruplet (i, j, i , j ), we have
where N is the total sample size. Therefore,
where
These expectations can be estimated by their empirical means to obtain the estimate of the covariance matrixΣ, which is used in our definition of the test statistic T c defined in equation (6). proposed U-statistics test with w k = 1; weighted U-stat: proposed U-statistics-based test with 
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Figure 4: Steroid hormone metabolism pathways with candidate genes for breast cancer in the WISE study. Genetic variants studied at these genes are shown in parentheses.
